Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2010 May 27;25(2):201–207. doi: 10.1007/s12291-010-0036-8

Effect of soy proteins Vs soy isoflavones on lipid profile in postmenopausal women

H K Jassi 1, A Jain 2, Sarika Arora 2,3,✉, R Chitra 1
PMCID: PMC3453111  PMID: 23105910

Abstract

Soy isoflavones and soy proteins are being considered as possible alternatives to postmenopausal hormone replacement therapy. This study was undertaken to evaluate effects of these two preparations on symptoms and lipid profile in postmenopausal women. The study was done in 75 postmenopausal women with FSH levels = 30 mIU/ml. These women were randomly divided into 3 groups (n=25). Study group I was given soy proteins 30gm/day containing 60 mg soy isoflavones. Study group II was given soy isoflavones (60 mg/day). The control group was given casein protein 30 gm/day. The menopausal symptoms were assessed by Kupperman Index. Fasting blood samples were analyzed for serum lipid profile, apolipoprotein A1 and B, Leutenizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) at the beginning of therapy, 4 and 12 weeks after initiation of therapy. A highly significant improvement in postmenopausal symptoms was observed in both the study groups. A highly significant improvement was seen in serum lipid profile and Apolipoprotein A1 and B in women taking soy proteins whereas women taking soy isoflavones demonstrated significant improvement in serum triglycerides only. Both soy proteins and soy isoflavones are helpful in alleviating postmenopausal symptoms but soy proteins offer a greater health advantage due to their beneficial effect on serum lipid profile.

Key Words: Soy proteins, Soy isoflavones, Lipid profile, Kupperman Index, Apolipoproteins, Postmenopausal symptoms

Full Text

The Full Text of this article is available as a PDF (76.7 KB).

References

  • 1.Faddy M.J., Gosden R.G. A model confirming the decline in follicle numbers to the age at menopause in women. Hum Reprod. 1996;11:1484–1486. doi: 10.1093/oxfordjournals.humrep.a019422. [DOI] [PubMed] [Google Scholar]
  • 2.Tchernof A., Poelhman E.T., Despr’es J.P. Body fat distribution, the menopause transition and Hormone Replacement Therapy. Diabet Metab. 2000;26(1):12–20. [PubMed] [Google Scholar]
  • 3.Woodruff J.D., Pickar J.H. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (premarin) with medroxyprogesterone acetate or conjugated estrogens alone: The Menopause Study Group. Am J Obstet Gynaecol. 1994;170:1213–1223. doi: 10.1016/s0002-9378(94)70129-6. [DOI] [PubMed] [Google Scholar]
  • 4.Writing Group for the Women’s Health Initiative. Risks and benefits of estrogen plus progestin in Healthy Postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333. doi: 10.1001/jama.288.3.321. [DOI] [PubMed] [Google Scholar]
  • 5.Cornwell T., Cohick W., Raskin I. Dietary phytoestrogens and health. Phytochem. 2004;65:995–1016. doi: 10.1016/j.phytochem.2004.03.005. [DOI] [PubMed] [Google Scholar]
  • 6.Albertazzi P., Pansini F., Bonaccorsi G., Zanotti L., Forini E., Aloysio D. The effect of soy supplements on hot flushes. Obstet Gynecol. 1998;91(1):6–11. doi: 10.1016/S0029-7844(97)00597-8. [DOI] [PubMed] [Google Scholar]
  • 7.Steward D.E. Alternative treatment for menopausal symptoms: systematic review of scientific and lay literature. Can Fam Physician. 1998;44:1299–1308. [PMC free article] [PubMed] [Google Scholar]
  • 8.Tham D.M., Gardner C.D., Haskell W.L. Potential health benefits of dietary phytoestrogens. A review of clinical epidemiology and mechanistic evidence. J Clin Endocrinol Metab. 1998;83(7):2223–2235. doi: 10.1210/jc.83.7.2223. [DOI] [PubMed] [Google Scholar]
  • 9.Kronenberg F., Fugh Bernan A. Complementary and alternative medicine for menopausal symptoms: a review of randomized controlled trials. Ann Intern Med. 2002;137(100):805–813. doi: 10.7326/0003-4819-137-10-200211190-00009. [DOI] [PubMed] [Google Scholar]
  • 10.Potter S.M., Baum J.A., Teng H., Stillman R.J., Shay N.F., Erdman J.W., Jr. Soy protein and isoflavones: their effects on blood lipids and bone mineral density in postmenopausal women. Am J Clin Metab. 1998;68(Suppl):1375–1395. doi: 10.1093/ajcn/68.6.1375S. [DOI] [PubMed] [Google Scholar]
  • 11.Kurzer M.S. Phytoestrogen supplement use by women. J Nutr. 2003;133(6):1983S–1986S. doi: 10.1093/jn/133.6.1983S. [DOI] [PubMed] [Google Scholar]
  • 12.Kupperman H.S., Blatt M.H., Weisbader H., Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol. 1953;13(6):688–703. doi: 10.1210/jcem-13-6-688. [DOI] [PubMed] [Google Scholar]
  • 13.Sethi H.K., Sidhu L.S., Singal P. Menopausal age and related factors. In: Sindhu L.S., Singh S.P., editors. Human Biology Global Development. Ludhiana: USG Publishers and Distributors.; 1996. pp. 137–151. [Google Scholar]
  • 14.Neslihan C.S., Bilge S.A., Ozturk T.N., Oya G., Ece O., Hamiyet B. The menopausal age, related factors and climacteric symptoms in Turkish women. Maturitas. 1998;30:37–40. doi: 10.1016/S0378-5122(98)00041-3. [DOI] [PubMed] [Google Scholar]
  • 15.Germain A., Peterson C., Robinson J., Alekel L. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause. 2001;8(1):17–26. doi: 10.1097/00042192-200101000-00005. [DOI] [PubMed] [Google Scholar]
  • 16.Murkies A.L., Wilcox G., Davis S.R. Phytoestrogens. J Clin Endocrinol Metab. 1998;83(2):297–303. doi: 10.1210/jc.83.2.297. [DOI] [PubMed] [Google Scholar]
  • 17.Baum J.A., Teng H., Erdman J.W., Weigel R.M., Klein B.P., Persky V.W., et al. Long-term intake of soy-protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor messenger RNA in hypercholesterolemic postmenopausal women. Am J Clin Nutr. 1998;68:545–551. doi: 10.1093/ajcn/68.3.545. [DOI] [PubMed] [Google Scholar]
  • 18.Hermansen K., Sondergaard M., Hoie L., Carstensen M., Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type II diabetic subjects. Diabetes Care. 2001;24:228–233. doi: 10.2337/diacare.24.2.228. [DOI] [PubMed] [Google Scholar]
  • 19.Tonstad K., Smerud K.T., Hoie L. A comparison of effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr. 2002;76:78–84. doi: 10.1093/ajcn/76.1.78. [DOI] [PubMed] [Google Scholar]
  • 20.Merz-Demlow B.E., Duncan A.M., Wangen K.E., Xu X., Carr T.P., Phipps W.R., Kurzer M.S. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000;71:1462–1469. doi: 10.1093/ajcn/71.6.1462. [DOI] [PubMed] [Google Scholar]
  • 21.Gardner C.D., Newell K.A., Cherin R., Haskell W.L. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr. 2001;73:728–735. doi: 10.1093/ajcn/73.4.728. [DOI] [PubMed] [Google Scholar]
  • 22.Crouse J.R., 3rd, Morgan T., Terry J.G., Ellis J., Vitolins M., Burke G.L. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med. 1999;159:2070–2076. doi: 10.1001/archinte.159.17.2070. [DOI] [PubMed] [Google Scholar]
  • 23.Nestel P.J., Yamashita T., Sasahara T., Pomeroy S., Dart A., Komesaroff P., Owen A., Abbey M. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol. 1997;17:3392–3398. doi: 10.1161/01.atv.17.12.3392. [DOI] [PubMed] [Google Scholar]
  • 24.Nestel P.J., Pomeroy S., Kay S., Komesaroff P., Behrsing J., Cameron J.D., West L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab. 1999;84:895–898. doi: 10.1210/jc.84.3.895. [DOI] [PubMed] [Google Scholar]
  • 25.Sirtori C.R., Gianazza E., Manzoni C., Lovati M.R., Murphy P.A. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. Am J Clin Nutr. 1997;65:166–167. doi: 10.1093/ajcn/65.1.166. [DOI] [PubMed] [Google Scholar]
  • 26.Greaves K.A., Wilson M.D., Rudel L.L., Williams J.K., Wagner J.D. Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. J Nutr. 2000;130:820–826. doi: 10.1093/jn/130.4.820. [DOI] [PubMed] [Google Scholar]
  • 27.Greaves K.A., Parks J.S., Williams J.K., Wagner J.D. Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J Nutr. 1999;129:1585–1592. doi: 10.1093/jn/129.8.1585. [DOI] [PubMed] [Google Scholar]
  • 28.Yeung J., Yu T.F. Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Nutr J. 2003;2:15–22. doi: 10.1186/1475-2891-2-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Weggemans R.M., Trautwein E.A. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr. 2003;57:940–946. doi: 10.1038/sj.ejcn.1601628. [DOI] [PubMed] [Google Scholar]
  • 30.Zhan S., Ho S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005;81:397–408. doi: 10.1093/ajcn.81.2.397. [DOI] [PubMed] [Google Scholar]
  • 31.Erdman J.W. AHA Science Advisory: Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation. 2000;102:2555–2559. doi: 10.1161/01.cir.102.20.2555. [DOI] [PubMed] [Google Scholar]
  • 32.Lovati M.R., Manzoni C., Gianazza E., Arnoldi A., Kurowska E., Carroll K.K., Sirtori C.R. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr. 2000;130:2543–2549. doi: 10.1093/jn/130.10.2543. [DOI] [PubMed] [Google Scholar]
  • 33.Gianazza E., Eberini I., Arnoldi A., Wait R., Sirtori C.R. A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies. J Nutr. 2003;133:9–14. doi: 10.1093/jn/133.1.9. [DOI] [PubMed] [Google Scholar]
  • 34.Foth D., Nawroth F. Effect of soy supplementation on endogenous hormones in Postmenopausal women. Gynecol Obstet Invest. 2003;55:135–138. doi: 10.1159/000071526. [DOI] [PubMed] [Google Scholar]
  • 35.Nikander E., Kilkkinen A., Metsa-Heikkila M., Adlercreutz H., Pietinen P., Tiitinen A., Ylikorkala O. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol. 2003;101:1213–1220. doi: 10.1016/S0029-7844(03)00232-1. [DOI] [PubMed] [Google Scholar]
  • 36.Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., Atteritano M., et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med. 2007;146:839–847. doi: 10.7326/0003-4819-146-12-200706190-00005. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES